| MIR223 |
|
microRNA 223
|
|
|
0.433 |
0.808 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| MIR15A |
|
microRNA 15a
|
|
|
0.482 |
0.808 |
| MIR182 |
|
microRNA 182
|
|
|
0.486 |
0.846 |
| LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
| LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
| MIR26B |
|
microRNA 26b
|
|
|
0.529 |
0.808 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| MIR16-1 |
|
microRNA 16-1
|
|
|
0.623 |
0.500 |
| IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
| CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
| H3P11 |
|
H3 histone pseudogene 11
|
|
|
0.711 |
0.385 |
| IGHV3-21 |
A0A0B4J1V1
|
immunoglobulin heavy variable 3-21
|
|
|
0.780 |
0.192 |
| CENPX |
A8MT69
|
centromere protein X
|
|
0.11 |
0.736 |
0.423 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
| BHLHE40 |
O14503
|
basic helix-loop-helix family member e40
|
Transcription factor
|
0.99 |
0.544 |
0.731 |
| KMT2D |
O14686
|
lysine methyltransferase 2D
|
|
1.00 |
0.465 |
0.808 |
| TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
| IKBKB |
O14920
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
Kinase
|
0.99 |
0.506 |
0.846 |
| SLC22A2 |
O15244
|
solute carrier family 22 member 2
|
Transporter
|
2.0E-12 |
0.572 |
0.769 |
| SLC7A4 |
O43246
|
solute carrier family 7 member 4
|
Transporter
|
2.8E-07 |
0.666 |
0.423 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| PLAT |
P00750
|
plasminogen activator, tissue type
|
Enzyme
|
5.7E-05 |
0.445 |
0.885 |